Hide metadata

dc.date.accessioned2019-12-11T20:05:15Z
dc.date.available2019-12-11T20:05:15Z
dc.date.created2018-10-16T14:00:11Z
dc.date.issued2018
dc.identifier.citationMorin, Eric Sjöberg, Elin Tjomsland, Vegard Testini, Chiara Lindskog, Cecilia Franklin, Oskar Sund, Malin Öhlund, Daniel Kiflemariam, Sara Sjöblom, Tobias Claesson-Welsh, Lena . VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival. Journal of Pathology. 2018, 246, 311-322
dc.identifier.urihttp://hdl.handle.net/10852/71585
dc.description.abstractUnstable and dysfunctional tumor vasculature promotes cancer progression and spread. Signal transduction by the pro‐angiogenic vascular endothelial growth factor (VEGF) receptor‐2 (VEGFR2) is modulated by VEGFA‐dependent complex formation with neuropilin 1 (NRP1). NRP1 expressed on tumor cells can form VEGFR2/NRP1 trans‐complexes between tumor cells and endothelial cells which arrests VEGFR2 on the endothelial surface, thus interfering with productive VEGFR2 signaling. In mouse fibrosarcoma, VEGFR2/NRP1 trans‐complexes correlated with reduced tumor vessel branching and reduced tumor cell proliferation. Pancreatic ductal adenocarcinoma (PDAC) strongly expressed NRP1 on both tumor cells and endothelial cells, in contrast to other common cancer forms. Using proximity ligation assay, VEGFR2/NRP1 trans‐complexes were identified in human PDAC tumor tissue, and its presence was associated with reduced tumor vessel branching, reduced tumor cell proliferation, and improved patient survival after adjusting for other known survival predictors. We conclude that VEGFR2/NRP1 trans‐complex formation is an independent predictor of PDAC patient survival.
dc.languageEN
dc.publisherLongman
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleVEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
dc.typeJournal article
dc.creator.authorMorin, Eric
dc.creator.authorSjöberg, Elin
dc.creator.authorTjomsland, Vegard
dc.creator.authorTestini, Chiara
dc.creator.authorLindskog, Cecilia
dc.creator.authorFranklin, Oskar
dc.creator.authorSund, Malin
dc.creator.authorÖhlund, Daniel
dc.creator.authorKiflemariam, Sara
dc.creator.authorSjöblom, Tobias
dc.creator.authorClaesson-Welsh, Lena
cristin.unitcode185,53,48,10
cristin.unitnameAvdeling for gastro- og barnekirurgi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin1620813
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Pathology&rft.volume=246&rft.spage=311&rft.date=2018
dc.identifier.jtitleJournal of Pathology
dc.identifier.volume246
dc.identifier.startpage311
dc.identifier.endpage322
dc.identifier.doihttps://doi.org/10.1002/path.5141
dc.identifier.urnURN:NBN:no-74711
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0022-3417
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/71585/1/Morin_et_al-2018-The_Journal_of_Pathology.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International